TrialJournal of neurology2013

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.

Michael Hutchinson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.